Drug Type Antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism EPRS inhibitors(Aminoacyl-tRNA synthetase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | South Korea | 22 Jan 2025 | |
Asthma | Preclinical | South Korea | 22 Jan 2025 | |
Asthma | Preclinical | Germany | 22 Jan 2025 | |
Idiopathic Pulmonary Fibrosis | Preclinical | South Korea | 22 Jan 2025 | |
Idiopathic Pulmonary Fibrosis | Preclinical | South Korea | 22 Jan 2025 | |
Idiopathic Pulmonary Fibrosis | Preclinical | Germany | 22 Jan 2025 |